Through rigorous peer review, robust research integrity standards, and open access publishing options, we support researchers and institutions to inform clinical practice, influence health policy, and improve public health and patient outcomes worldwide.

We publish official journals on behalf of and in partnership with internationally recognised medical societies, including the American Thoracic Society, British Cardiovascular Society, Royal College of Paediatrics and Child Health, and British Society of Gastroenterology, strengthening specialist communities and advancing clinical standards across disciplines.

BMJ Journals cover the full spectrum of medicine and health, including:

• Clinical medicine across specialties

• Public health and population health

• Health policy and systems

• Quality improvement and patient safety

• Medical education

• Global health and health equity

• Strong clinical orientation with emphasis on practice change

• High standards of transparency and research integrity

• Established reputation for publishing influential clinical research and guidelines

• Active engagement with policy and healthcare leaders

• Integrated multimedia and digital dissemination

• Indexed in major bibliographic databases with strong impact metrics across specialties

We’ve been publishing trusted medical research for over 185 years. Today, our 70 strong journal portfolio spans clinical specialties, public health, and emerging fields. Every title in our portfolio delivers the most rigorous and reliable evidence needed to shape policy, guide clinical decisions, and advance global health.

The Journal Impact Factor (JIF) is a widely used measure of average citations. It is often seen as a sign of a journal’s influence, but no single metric tells the whole story.

As a DORA signatory, BMJ Group supports a more balanced view of research impact. Alongside JIF, we share CiteScore, Altmetric mentions, time to first decision, and more, all available on our journal sites. These metrics help institutions assess quality, reach and speed, and make informed decisions about where to subscribe and publish.

While scholarly influence is important, its true value lies in its implications for policy and clinical guidelines, and in driving meaningful change in health and social care.

Typically, research takes five to 15 years to impact clinical guidelines. Various factors influence this timeline, from the quality and strength of evidence to peer review, publication, design development processes, consensus, and clinical adoption. BMJ Group’s brand recognition and global reach can accelerate this process by improving clinical practice worldwide.

It’s a very highly regarded journal, and we felt incredibly lucky. It’s been really positive. If anyone ever asks me within WHO, if I have any suggestions for how to do things, BMJ Global Health will be my first recommendation.”

Joanna Esteves Mills
Global public health consultant and coordinator of the WHO’s guideline development process

If you are developing a guideline, funding a research programme, or seeking to consolidate evidence for policy impact, our partnerships team can advise on models that align publication strategy with implementation timelines.

Research that improves patients’ lives matters deeply to the funders, institutions and researchers who dedicate their resources to medical and health research. But evaluating the impact of this research on policy and guidelines is traditionally measured by standard scholarly metrics in the absence of more targeted analysis that relates explicitly to health improvement.

BMJ Impact Analytics makes it easy to find, track, and share the real-world impact of research on health and social care. If you fund, publish or produce research or policy, we track where it’s cited in clinical guidance and health policy worldwide.

Identify the impact of your medical research
Developed with universities and research funders, BMJ Impact Analytics is the only analytics tool focused exclusively on health and social care.

Make decisions with confidence
Access a comprehensive, curated database of citation evidence from clinical research, health policy, guidelines, and grey literature, updated daily by BMJ experts.

Connect research to patient care
Track how your research informs local and national guidelines, clinical tools, and frontline decision making.

Target funding to improve outcomes
Assess impact, identify gaps, and direct research investment where it can influence health outcomes most effectively.

See impact in context
Understand the reach and policy relevance of your citations across health systems.

Share your impact story
Generate clear, evidence based insights for funders, institutions, and public reporting.

BMJ Impact Analytics

Helping researchers, institutions, and partners to:

🧩 Prove influence: evidence of real world policy citations to help strengthen future funding bids

🌐 Stay relevant: understand how and where research is being used

🚦 Inform strategy: use citation insights to guide future publications and stakeholder engagement

🛡️ Demonstrate accountability: especially vital for organisations producing commissioned research

As funders increasingly demand proof that research leads to real change, BMJ Impact Analytics helps researchers secure future funding by clearly demonstrating the impact of their work on academic knowledge and clinical practice.

At BMJ Group, we bring people together for discussion, debate, and learning through our series of events — some in person and, increasingly, some delivered virtually.

“The opportunities that BMJ Group presents through the events they lead are far reaching. They have the potential to change perceptions and mindsets of both healthcare professionals and the regulators of the healthcare systems within which they operate.”

Ian Leistikow
Inspector at Dutch Health and Youth Care Inspectorate and Professor at Erasmus University

Niels will lead all global publishing activities for the healthcare knowledge provider. This includes the world-renowned journal The BMJ, and nearly 70 speciality journals, alongside the Group’s Events, Careers, and Learning businesses.

Niels brings over 20 years of international leadership experience within the Springer Group. He joins from Springer Nature, where he most recently served as Executive Vice President/Managing Director, Books, overseeing the world’s largest academic books programme. His previous roles include President of Springer Nature Greater China and Managing Director for the Iversity e-learning platform.

Niels Peter Thomas commented: “I am excited to join BMJ Group at this important time in its international growth journey. I look forward to working with a team of highly respected publishing leaders and collaborating with researchers and partners to ensure sustainable growth that delivers a long-term positive impact globally”. 

 Niels Peter Thomas, newly appointed CEO, BMJ Publishing